FDA approved Beyfortus (nirsevimab-alip) for preventing Respiratory Syncytial Virus (RSV) in neonates and infants. Do you know how to say the generic name? nir-SEV-uh-mab--Ay-El-Eye-Pee
You are viewing a robot-friendly page.Click hereto reload in standard format.